Waters (WAT) | Stock Overview & Key Data
Waters Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $428.22 on September 6, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Waters WAT | 21.00B Large-cap | -16.74% | -16.75% | -10.47% | -27.19% | -21.37% | 0.48% | -12.01% | 36.37% |
| Thermo Fisher TMO | 160.56B Large-cap | -1.92% | 3.19% | -5.22% | -24.20% | -20.01% | -20.40% | -24.25% | 4.67% |
| Danaher DHR | 146.61B Large-cap | -3.90% | -4.10% | 1.55% | -18.96% | -16.08% | -18.80% | -18.54% | 14.23% |
| Idexx Laboratories IDXX | 42.50B Large-cap | -2.26% | -0.40% | 30.35% | 24.53% | 28.81% | 13.50% | 35.05% | 47.93% |
| Agilent Technologies A | 35.02B Large-cap | -6.67% | -5.11% | 9.52% | -20.59% | -15.36% | -8.88% | -3.97% | 26.65% |
| Iqvia Holdings IQV | 27.70B Large-cap | -4.13% | -0.99% | 5.72% | -19.59% | -19.19% | -28.69% | -27.78% | 1.43% |
Ownership & Short Interest
Waters Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Waters would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
What is WAT's 52-week high and low?
In the last 52 weeks, Waters reached a high of $423.56 (on January 30, 2025) and a low of $287.02 (on July 15, 2025).
What is the market cap and P/E ratio for WAT?
Curious about Waters's size and valuation? Its market capitalization stands at 21.00B. When it comes to valuation, the P/E ratio (trailing twelve months) is 32.05, and the forward P/E (looking ahead) is 27.29.
Does WAT pay dividends? If so, what's the yield?
As for dividends, Waters isn't currently offering a significant yield, or that specific data isn't available right now.
Who are Waters's main competitors or similar companies to consider before investing?
When looking at Waters, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
| Company | Mkt Cap | Sector | Industry | 1Y Return | 3Y Return |
|---|---|---|---|---|---|
| Thermo Fisher TMO | 160.56B | Healthcare | Diagnostics & Research | -20.40% | -24.25% |
| Danaher DHR | 146.61B | Healthcare | Diagnostics & Research | -18.80% | -18.54% |
| Idexx Laboratories IDXX | 42.50B | Healthcare | Diagnostics & Research | 13.50% | 35.05% |
| Agilent Technologies A | 35.02B | Healthcare | Diagnostics & Research | -8.88% | -3.97% |
| Iqvia Holdings IQV | 27.70B | Healthcare | Diagnostics & Research | -28.69% | -27.78% |
For a more comprehensive list, please see the Peer Performance Comparison table on this page.
What are the key financial health indicators for Waters Corporation? (e.g., ROE, Debt/Equity)
To get a sense of Waters's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 40.82%, the Debt to Equity ratio from the most recent quarter is 78.58, and its Gross Profit Margin stands at 58.18%.
What is the recent revenue and earnings growth for WAT?
Looking at Waters's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.90%, and quarterly earnings saw a YoY growth of 18.80%.
How much of WAT stock is held by insiders and institutions?
Wondering who owns Waters stock? Company insiders (like executives and directors) hold about 0.16% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 98.19%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.